Xponance LLC’s Eli Lilly & Co Position
Does Xponance LLC own Eli Lilly & Co (LLY)? Yes — 226.8K shares worth $209M (+1.48% of its 13F portfolio) as of Q1 2026, up from 208.3K shares the prior filed quarter.
Position Value
$209M
Q1 2026
Shares
226.8K
% of Portfolio
+1.48%
Quarters Held
24
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 226.8K | $209M | +1.48% |
| Q4 2025 | 208.3K | $224M | +1.68% |
| Q3 2025 | 197.1K | $150M | +1.19% |
| Q2 2025 | 197.9K | $154M | +1.29% |
| Q1 2025 | 191.2K | $158M | +1.53% |
| Q4 2024 | 186.5K | $144M | +1.31% |
| Q3 2024 | 186.7K | $165M | +1.60% |
| Q2 2024 | 194.8K | $176M | +1.80% |
| Q1 2024 | 195.1K | $152M | +1.59% |
| Q4 2023 | 191.0K | $111M | +1.33% |
| Q3 2023 | 189.3K | $102M | +1.38% |
| Q2 2023 | 188.7K | $88M | +1.18% |
| Q1 2023 | 167.0K | $57M | +0.84% |
| Q4 2022 | 162.8K | $60M | +0.96% |
| Q3 2022 | 146.3K | $47M | +0.91% |
| Q2 2022 | 135.9K | $44M | +0.89% |
| Q1 2022 | 135.1K | $39M | +0.64% |
| Q4 2021 | 119.6K | $33M | +0.52% |
| Q3 2021 | 122.7K | $28M | +0.54% |
| Q2 2021 | 133.9K | $31M | +0.56% |
| Q1 2021 | 149.4K | $28M | +0.59% |
| Q4 2020 | 149.9K | $25M | +0.55% |
| Q3 2020 | 149.0K | $22M | +0.54% |
| Q2 2020 | 157.0K | $26M | +0.67% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Xponance LLC’s full portfolio or all institutional holders of LLY.